OSI Pharmaceuticals

Organisation

Trials

  • NCT01334710

    Collaborator, Phase 2, Terminated, 3 people, 13 Apr 2011

  • NCT01154335

    Collaborator, Phase 1, Completed, 18 people, 30 Jun 2010

  • NCT01032070

    Phase 2, Terminated, 25 people, 15 Dec 2009

  • NCT00942734

    Collaborator, Phase 2, Completed, 49 people, 21 Jul 2009

  • NCT00871923

    Collaborator, Phase 2, Completed, 44 people, 30 Mar 2009

  • NCT00826449

    Collaborator, Phase 1/2, Completed, 53 people, 22 Jan 2009

  • NCT00696696

    Collaborator, Phase 2, Completed, 45 people, 13 Jun 2008

  • NCT00672243

    Collaborator, Phase 2, Completed, 32 people, 6 May 2008

  • NCT00642746

    Collaborator, Phase 2, Terminated, 16 people, 25 Mar 2008

  • NCT00640978

    Collaborator, Phase 2, Terminated, 16 people, 21 Mar 2008

  • NCT00609804

    Collaborator, Phase 2, Completed, 53 people, 7 Feb 2008

  • NCT00591123

    Collaborator, Phase 2, Completed, 38 people, 11 Jan 2008

  • NCT00570258

    Collaborator, Phase 2, Terminated, 27 people, 10 Dec 2007

  • NCT00499655

    Collaborator, Phase 2, Completed, 107 people, 11 Jul 2007

  • NCT00304278

    Collaborator, Phase 2, Completed, 21 people, 17 Mar 2006

  • NCT00294762

    Phase 2, Completed, 143 people, 22 Feb 2006

  • NCT00140556

    Collaborator, Early phase 1, Completed, 28 people, 1 Sept 2005

  • NCT00123851

    Collaborator, Phase 2, Completed, 32 people, 26 Jul 2005

  • NCT00116896

    Phase 1, Completed, 25 people, 1 Jul 2005

  • NCT00088270

    Phase 2, Completed, 58 people, 26 Jul 2004